Akero Therapeutics, Inc. (NASDAQ:AKRO) CTO Sells $46,504.32 in Stock
MarketBeat
Akero Therapeutics, Inc. (NASDAQ:AKRO - Get Free Report) CTO Scott A. Gangloff sold 848 shares of the firm's stock in a transaction that occurred on Wednesday, June 18th. The stock was sold at an average price of $54.84, for a total transaction of $46,504.32. Following the completion of the transaction, the chief technology officer now directly owns 23,452 shares in the company, valued at approximately $1,286,107.68. The trade was a 3.49% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink.
NASDAQ:AKRO